Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer - Concepedia

Concepedia

Publication | Open Access

Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor–Positive Breast Cancer

DOI Full Paper Access

12

Citations

23

References

2022

Year

Joline S.J. Lim, Andrea L.A. Wong, Samuel G.W. Ow, Natalie Y.L. Ngoi, Gloria Chan, Yvonne Ang, Wan Qin Chong, Siew Eng Lim, Yi Wan Lim, Matilda Lee,

Clinical Cancer Research

Abstract

Lenvatinib plus letrozole had manageable toxicity, with target engagement and preliminary antitumor activity observed, supporting further assessment in randomized studies.

References

	Year	Citations

Page 1